Judge weighs “fairness” of $7.25 billion Roundup settlement for cancer victims
Opposing teams of attorneys spent hours on Monday battling over a proposed $7.25 billion settlement of the US Roundup cancer litigation that, if approved, would allow Bayer to keep selling its controversial glyphosate weed killers while providing roughly $10,000 to $165,000 for individuals suffering from cancer they blame on Roundup use.